President Emeritus of @BiocomCA Leading advocacy across California and in Washington, DC for our life science industry and for the patients that we serve.
We are pleased to announce an MOU with @BioindustryPark Silvano Fumero in Italy’s Piedmont region to advance collaboration between our life science ecosystems. This partnership supports innovation, funding opportunities, technology exchange and global engagement for our members.
Thank you @US_FDA Director Jeff Shuren for your 15 years of service leading CDRH and for your commitment to improving medical device regulatory processes. It has been an honor to work in collaboration with you all these years.
Such a pleasure spending time with @biocom President & CEO Joe Panetta at #BioKorea2024 – exploring opportunities to build durable international connections to support the biotech sector & company growth. And more discussions to come at #BIO in San Diego.
We’ve wrapped up another successful #BiocomCAFlyIn here in Washington, D.C. Members discussed all things #emergingtech these past two days. Thank you to all the offices who took time out of their day to meet with us!
Our @ARPAHealth roundtable just started in San Diego with a full house of companies looking to partner and engage with this exciting new agency. Attendees are hearing directly from Director @rwegrzyn, Deputy Director, and program managers on best ways to work with the agency.
Tonight President Biden continued his attacks on our biotechnology industry, proposing to increase drugs under already harmful price controls to 500. These reckless actions not only threaten innovative US drug discovery, they will prevent patient access to life saving drugs.
From California: Today we are at @biocom's Global Partnering and Investor Conference in La Jolla. Biocom CEO Joseph Panetta talks about the event and the state of California's three major biotech hubs.
Full video: https://t.co/rAdrbJPbHm
Get ready for the premier life science partnering event of the year. The Global Life Science Partnering and Investor Conference begins tomorrow. Plan your week in advance by viewing the agenda: https://t.co/DKJSlwuQDV
#BiocomGPIC
As we kick off #RareDiseaseWeek, I am proud to celebrate @biocom members focused on treating rare diseases and reaffirm our united commitment to support those affected. Together, we can drive progress and make a meaningful difference.
We @biocom and our members extend heartfelt congratulations to John Crowley on his appointment as CEO of #BIO. John, your leadership journey is an inspiration; we are thrilled to embark with you on our shared mission of improving the world through biotechnology.
Today, the CA life science industry mourns the loss of Senator Dianne Feinstein. @BIOCOMCEO shares, “Her passing marks the loss of one of California's most ardent supporters, and Biocom California extends its heartfelt gratitude for her unwavering dedication to life science.”
Today, Biocom California signed memorandums of understanding with two Korean organizations, KIMCo and KPBMA, to promote cooperation in economic relations, trade, and investment between Korea and the US.
California continues to be the leading innovation hub for the life science industry, and the 2023 Economic Impact Report provides key data on the impact it has on the state and regional economies https://t.co/JApjxs5306
Sometimes the seemingly less significant Supreme Court rulings are the most impactful. Congrats to Geraldine Tyler.
#94-year-old grandmother gets big win at Supreme Court
https://t.co/NM3tcxN52X
Excited to follow up my meeting last month with @CALtGovernor in San Diego, continuing the discussion with @biocom's Board on the importance of the life science industry in California. We were honored to have her and look forward to working together more in the future.
Today, the life science industry mourns the loss of a dedicated leader. @SoCalBio Ahmed Enany’s fierce determination, vision, and dedication to the LA biotech community was legendary. All of us at Biocom California will remember his amazing contributions to the industry.
In @Newsweek’s The New Era of Life Sciences Report, @BIOCOMCEO explains how the industry has changed over the past three decades and the outlook for continued growth. Read the full interview: https://t.co/rei6c73f84
Why are drug prices so high? RealClearMarkets Explains:
Pharmacy Benefit Managers Are An Unsung Source of High Drug Prices | RealClearMarkets https://t.co/5KED8Q97Ky
Thank you @US_FDA#DHCoE Director Tazbaz for sharing your center's priorities and engaging in a thought-provoking roundtable today. It was a great discussion, and we look forward to advancing #digitalhealth together! Thank you @LillyPad Gateway Labs for hosting us.